Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences.
about
The rationale for consuming cognitive enhancement drugs in university students and teachersEvaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristicsImpact of contextual factors and substance characteristics on perspectives toward cognitive enhancementAddiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsModeling students' instrumental (mis-) use of substances to enhance cognitive performance: Neuroenhancement in the light of job demands-resources theoryAssociations Between the Big Five Personality Traits and the Non-Medical Use of Prescription Drugs for Cognitive Enhancement.To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students.Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany.A survey of substance use for cognitive enhancement by university students in the NetherlandsThe Use of Prescription Drugs, Recreational Drugs, and "Soft Enhancers" for Cognitive Enhancement among Swiss Secondary School Students.Neuroenhancement and the strength model of self-control.Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students' everyday life "doping"Drugs As Instruments: Describing and Testing a Behavioral Approach to the Study of Neuroenhancement.Use of neuroenhancement drugs: prevalence, frequency and use expectations in Switzerland.Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects.Prescription stimulant medication misuse: Where are we and where do we go from here?Work-related stress and cognitive enhancement among university teachers.Prevalence of and motives for pharmacological neuroenhancement in Switzerland--results from a national Internet panel.Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets.
P2860
Q21089765-87887F15-C549-4468-9188-154B4231843CQ21203313-4BD811C7-3264-473C-9FAE-E7BA5DF0FFBEQ21558807-08F062AA-5461-4EBE-87A9-B3BD258BFF3AQ22251215-909034C7-86CC-4C45-9E42-52132B3F59F7Q33713093-3D09905B-D706-4F82-9399-B71F11A28114Q34509493-1A8A5FF0-1DDB-4A46-9202-CEE003626126Q35043495-281CCC83-6335-4860-9944-98443053C3B2Q35084473-AECBFB9E-28FF-46CF-A21E-65E85BE96909Q35089860-DB377059-12EC-4BEB-90AD-FF6498FE9624Q35822721-A59AF736-57D5-4CC6-BBFF-F1FA2270F7A9Q36098295-4DF60FF1-00C6-4CFD-A4D6-D18B2935BF13Q36972628-73674ACE-8EDF-4C62-A385-5D7E8AA74DE6Q37180741-5F89C900-6BE8-4539-82EE-65805261E8B7Q37703273-260AF5E0-75EB-4765-BA2A-1085263687E6Q38248567-C21C4E9D-DDA1-42D5-A279-6B7CFE9C6219Q38815927-A361274D-72F7-4064-800B-B281E07FFC8FQ39031942-18C5256A-4D02-471B-BA99-194D34DE4FC6Q41572093-FCC5A4BB-4DD8-4FFB-BAD3-A64F8030F932Q55405889-F2FA72F1-5C8E-4DBE-9711-2DC0A5EBE71D
P2860
Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cognitive-enhancing substance ...... easons and gender differences.
@en
Cognitive-enhancing substance ...... easons and gender differences.
@nl
type
label
Cognitive-enhancing substance ...... easons and gender differences.
@en
Cognitive-enhancing substance ...... easons and gender differences.
@nl
prefLabel
Cognitive-enhancing substance ...... easons and gender differences.
@en
Cognitive-enhancing substance ...... easons and gender differences.
@nl
P2093
P2860
P1476
Cognitive-enhancing substance ...... easons and gender differences.
@en
P2093
Burghard F Klapp
Karin Vitzthum
Patrick Eickenhorst
Stefanie Mache
P2860
P2888
P304
P356
10.1007/S10354-012-0115-Y
P577
2012-06-16T00:00:00Z